Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Beraprost sodium (modified release tablet)

EU orphan designation number: EU/3/08/554   
Active ingredient: Beraprost sodium (modified release tablet)
Indication: Treatment of pulmonary arterial hypertension
Sponsor: IDEA Innovative Drug European Associates Limited
The Jeffrey’s Building, St John’s Innovation Park, Cowley Road, Cambridge, CB4 0DS, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/07/2008 Centralised Orphan - Designation EMEA/OD/018/08 (2008)3658 of 10/07/2008
28/02/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/018/08/T/01 (2012)886 of 09/02/2012
17/12/2012 Other procedure